eCOA
Framework
Digital outcome capture
ePRO
Subset
Patient-reported only
DHT
Signals
Objective device-generated data
Modern Endpoint Model
Assessments + devices + recovery workflows
These categories overlap in modern trials, but each has a distinct role in how outcome data are captured and interpreted.
In simple terms, eCOA is the umbrella, ePRO is one branch under that umbrella, and DHT adds continuous or passive objective signal that sits alongside structured assessments.
Related reading: eCOA & ePRO platform
The main difference is not whether they are digital. The difference is what kind of data they collect, how often they collect it, and what role they play in endpoint strategy.
The structured digital capture of clinical outcomes across patient, clinician, observer, and performance-based assessments.
A patient-reported subset of eCOA used for diaries, symptoms, quality of life, burden, and direct patient experience.
Connected technologies that generate objective digital measures such as activity, heart rate, sleep, respiratory data, or glucose trends.
eCOA and ePRO are often episodic or scheduled; DHT can be passive, continuous, or near-continuous depending on the device.
ePRO is subjective, DHT is objective, and eCOA can include both subjective and structured non-patient-reported assessments.
ePRO risks missed entries, while DHT risks wear-time decay, battery issues, sync failures, and silent data gaps.
These differences matter because each modality fails in a different way and requires a different recovery model.
The best modern trials do not choose between them. They decide how to combine them intentionally.
Each of these tools captures a different dimension of treatment effect and patient experience.
For example, a patient may report worse fatigue in an ePRO diary while a wearable shows declining activity and sleep disruption. Together, these signals tell a stronger story than either would alone.
See related pages: Wearables · Digital Biomarkers · Analytics
The more data streams a trial combines, the more important execution becomes. Problems usually start when these systems are deployed in parallel but managed separately.
ePRO can fail through missed entries, while DHT can fail through non-wear, battery depletion, or sync issues.
When assessments, devices, logistics, and support live across multiple teams, nobody owns end-to-end data continuity.
Without a coordinated model, research sites absorb task recovery, troubleshooting, and follow-up that should be operationalized elsewhere.
By the time issues are seen in monitoring review, the best recovery window may already be gone.
Even with good tools, the study loses value when subjective and objective signals are not harmonized properly.
The most common gap is not launch. It is the absence of a structured response model once compliance begins to drift.
This is why successful studies treat assessments, devices, and oversight as one operating system—not three disconnected categories.
Trials that combine eCOA, ePRO, and DHT effectively do not just deploy tools. They coordinate workflows, define thresholds, and act quickly when one stream begins to drift.
When these elements are aligned, eCOA, ePRO, and DHT reinforce one another instead of creating additional fragmentation.
No. ePRO is one subset of eCOA. eCOA includes ePRO along with clinician-reported, observer-reported, and performance-based digital assessments.
Not exactly. Wearables are generally considered Digital Health Technologies. They complement eCOA and can be used alongside it to create richer endpoint strategies.
Because subjective symptoms, structured outcome assessments, and objective real-world signals together provide a more complete picture of patient status and treatment effect.
Delve combines digital assessments, wearables, analytics, and human support into one compliance-focused operating model designed to protect completion, reduce burden, and strengthen endpoint integrity.
Book a Strategy Walkthrough